antibody therapeutics (GPC Biotech)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantibody therapeutics (GPC Biotech)
Drug Alias NameMHC II antibody (Debiopharm/GPC Biotech)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGpc Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGpc Biotech
Active IndicationsN/A
Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A